Concepedia

Harald Fjällbrant

HF

7

Publications

301

Citations

7

H-Index

2001

Active since

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United Kingdom)

Karolinska Institutet

University of Gothenburg

Harald Fjällbrant is an author at AstraZeneca (Sweden) specializing in medicine, pharmacotherapy, and vaccination.

Top concepts

MedicinePharmacotherapyAsthmaAllergyPediatricsDermatologyVaccinationPharmacologyTuberculosisClinical Trials

Publications per year

2001–2024

7

Publications

7

Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone

Stephen P. Peters, Eugene R. Bleecker, Giorgio Walter Canonica et al. · New England Journal of Medicine · 2016 · 108 citations · Full text

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis

Marc E. Rothenberg, Evan S. Dellon, Margaret H. Collins et al. · New England Journal of Medicine · 2024 · 78 citations

A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD

François Maltais, Gary T. Ferguson, Gregory Feldman et al. · Advances in Therapy · 2019 · 49 citations

Asthma, Pulmonary Care, Medicine +5

BCG scar and tuberculin reactivity in children and adults

Harald Fjällbrant, Malin Ridell, Lars Olof Larsson · Scandinavian Journal of Infectious Diseases · 2008 · 23 citations

Vaccination, Bcg Vaccination, Pulmonary Tuberculosis +11

Primary vaccination and revaccination of young adults with BCG: A study using immunological markers

Harald Fjällbrant, Malin Ridell, Lars Olof Larsson · Scandinavian Journal of Infectious Diseases · 2007 · 16 citations

Rows per page

1–5 of 7